The Emerging Technology Observatory will be sunsetting PARAT effective May 11, 2026. For more details and information on how you can continue to access underlying data, see our recent blog post.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
Crunchbase, retrieved 2024-05-16| Country | United States |
|---|---|
| Sector | Pharmaceuticals & Medical Research |
| Website | http://www.regeneron.com/ |
Between 2015 and 2025, Regeneron Pharmaceuticals researchers released31 AI research articles
- #165in PARAT for number of AI research articles
- 13.26citations per AI article on average (#265 in PARAT, #158 in the S&P 500)
- 3highly cited articles (#145 in PARAT, #67 in the S&P 500)
- +301.7%growth in Regeneron Pharmaceuticals's public AI research (2020–2023)
- 1articles at top AI conferences (#162 in PARAT, #79 in the S&P 500)
- 0.7%of Regeneron Pharmaceuticals's total public research was AI-focused
Regeneron Pharmaceuticals's top AI research topics
Subfield | Articles | Citations per article | Growth (2020–2023) |
|---|---|---|---|
| CV publications | 9 | 6.6 | -50 |
| NLP publications | 3 | 17.3 | -100 |
| Robotics publications | 0 | 0 | N/A |
| AI safety publications | 0 | 0 | N/A |
| Large language model publications | 3 | 24.7 | N/A |
Between 2015 and 2025, Regeneron Pharmaceuticals filed19 AI-related patents
- #222in PARAT for number of AI-related patents filed
- 0%growth in Regeneron Pharmaceuticals's AI-related patent filing (2017–2020)
- 2AI-related patents were granted to Regeneron Pharmaceuticals (2017–2020)
- 1.4%of Regeneron Pharmaceuticals's filed patents were AI-related
Top AI application areas across Regeneron Pharmaceuticals's filed patents
Subfield | Patents filed | Growth (2017–2020) |
|---|---|---|
| Analytics and algorithms patents | 5 | N/A |
| Computer vision patents | 1 | N/A |
| Language processing patents | 0 | N/A |
| Speech processing patents | 0 | N/A |
| Knowledge representation patents | 0 | N/A |
Top use cases across Regeneron Pharmaceuticals's filed AI patents
Subfield | Patents filed | Growth (2017–2020) |
|---|---|---|
| Life sciences patents | 14 | N/A |
| Personal devices and computing patents | 3 | -100% |
| Physical sciences and engineering patents | 1 | N/A |
| Security patents | 1 | N/A |
| Transportation patents | 0 | N/A |
156
AI jobs
According to our data, Regeneron Pharmaceuticals currently employs about 156 AI workers (#208 rank in PARAT, #154 in the S&P 500). AI workers in PARAT include anyone a high probability of working with AI. Recent hires may be omitted. Read more >>
508
Tech Team 1 jobs
According to our data, Regeneron Pharmaceuticals currently employs about 508 Tech Team 1 workers (#345 rank in PARAT, #267 in the S&P 500).Tech Team 1 workers include anyone with technical skills and a reasonable probability of working with AI. Recent hires may be omitted. Read more >>
The AI activity metrics in the Private-Sector AI Indicators dataset are derived from data from Revelio Labs, ETO's Merged Academic Corpus, and other sources. Additional descriptive metadata in PARAT comes from the Crunchbase Open Data Map (powered by Crunchbase) and PermID. Emerging technology topic classifications are based on work supported in part by the Alfred P. Sloan Foundation under Grant No. G-2023-22358. For details on our sourcing, methodology, and limitations, see the tool documentation.